{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:04:46Z","timestamp":1792091086984,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["schres-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.schres.2013.08.001","type":"journal-article","created":{"date-parts":[[2013,8,21]],"date-time":"2013-08-21T20:15:50Z","timestamp":1377116150000},"page":"408-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":186,"title":["Risk of symptom recurrence with medication discontinuation in first-episode psychosis: A systematic review"],"prefix":"10.1016","volume":"152","author":[{"given":"Robert B.","family":"Zipursky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasja M.","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Streiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.schres.2013.08.001_bb0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.amepre.2008.11.020","article-title":"Obesity among those with mental disorders: a National Institute of Mental Health meeting report","volume":"36","author":"Allison","year":"2009","journal-title":"Am. J. Prev. Med."},{"issue":"3","key":"10.1016\/j.schres.2013.08.001_bb0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1819.2008.01790.x","article-title":"Predictors of violent behavior among acute psychiatric patients: clinical study","volume":"62","author":"Amore","year":"2008","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.schres.2013.08.001_bb0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3109\/13651501.2010.534801","article-title":"Antipsychotic prophylaxis is needed after remission from a first psychotic episode in schizophrenia patients: results from an aborted randomised trial","volume":"15","author":"Boonstra","year":"2011","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"11","key":"10.1016\/j.schres.2013.08.001_bb0020","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1176\/appi.ajp.2011.11010048","article-title":"Diagnostic shifts during the decade following first admission for psychosis","volume":"168","author":"Bromet","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.schres.2013.08.001_bb0025","first-page":"25S","article-title":"Canadian clinical practice guidelines for the treatment of schizophrenia","volume":"43","author":"Canadian Psychiatric Association","year":"1998","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.schres.2013.08.001_bb0030","doi-asserted-by":"crossref","first-page":"c4024","DOI":"10.1136\/bmj.c4024","article-title":"Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial","volume":"341","author":"Chen","year":"2010","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.schres.2013.08.001_bb0035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies","volume":"161","author":"Correll","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2013.08.001_bb0040","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jpsychires.2010.11.002","article-title":"Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine","volume":"45","author":"Crespo-Facorro","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2013.08.001_bb0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.148.2.120","article-title":"A randomised controlled trial of prophylactic neuroleptic treatment","volume":"148","author":"Crow","year":"1986","journal-title":"Br. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2013.08.001_bb0050","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.clinthera.2008.12.020","article-title":"Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies","volume":"30","author":"Emsley","year":"2008","journal-title":"Clin. Ther."},{"issue":"4","key":"10.1016\/j.schres.2013.08.001_bb0055","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.4088\/JCP.11m07138","article-title":"Symptom recurrence following intermittent treatment in first-episode schizophrenia successfully treated for 2years: a 3-year open-label clinical study","volume":"73","author":"Emsley","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2013.08.001_bb0060","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2013.08.001_bb0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0920-9964(01)00182-7","article-title":"First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies","volume":"53","author":"Gaebel","year":"2002","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.schres.2013.08.001_bb0070","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4088\/JCP.v68n1116","article-title":"Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia","volume":"68","author":"Gaebel","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2013.08.001_bb0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/JCP.09m05459yel","article-title":"Relapse prevention in first-episode schizophrenia\u2014maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia","volume":"72","author":"Gaebel","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2013.08.001_bb0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00005053-197411000-00004","article-title":"Are antipsychotic drugs interchangeable?","volume":"159","author":"Gardos","year":"1974","journal-title":"J. Nerv. Ment. Dis."},{"issue":"3","key":"10.1016\/j.schres.2013.08.001_bb0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpsyc.1995.03950150005001","article-title":"Neuroleptic withdrawal in schizophrenic patients. A review of the literature","volume":"52","author":"Gilbert","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2013.08.001_bb0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1192\/bjp.bp.110.081471","article-title":"Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial","volume":"199","author":"Girgis","year":"2011","journal-title":"Br. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2013.08.001_bb0095","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.158.11.1835","article-title":"Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia","volume":"158","author":"Gitlin","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2013.08.001_bb0100","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4088\/JCP.08m04407","article-title":"A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients","volume":"70","author":"Gleeson","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2013.08.001_bb0105","series-title":"Clinical global impressions, ECDEU assessment manual for psychopharmacology","first-page":"218","author":"Guy","year":"1976"},{"issue":"10","key":"10.1016\/j.schres.2013.08.001_bb0110","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1017\/S0033291712000220","article-title":"Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study","volume":"42","author":"Harrow","year":"2012","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.schres.2013.08.001_bb0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archpsyc.1991.01810280049007","article-title":"Intermittent vs maintenance medication in schizophrenia. Two-year results","volume":"48(","author":"Herz","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3\u20134","key":"10.1016\/j.schres.2013.08.001_bb0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-3956(97)00013-7","article-title":"The limitations of antipsychotic medication on schizophrenia relapse and adjustment and the contributions of psychosocial treatment","volume":"32","author":"Hogarty","year":"1998","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.schres.2013.08.001_bb0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1359786810385490","article-title":"Suicide and schizophrenia: a systematic review of rates and risk factors","volume":"24","author":"Hor","year":"2010","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2013.08.001_bb0130","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1017\/S0033291700026337","article-title":"Kraepelin revisited: a reassessment and statistical analysis of dementia praecox and manic-depressive insanity in 1908","volume":"23","author":"Jablensky","year":"1993","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2013.08.001_bb0135","series-title":"The Recognition and Management of Early Psychosis: A Preventive Approach","author":"Jackson","year":"2009"},{"issue":"6756","key":"10.1016\/j.schres.2013.08.001_bb0140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/bmj.301.6756.837","article-title":"Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years","volume":"301","author":"Jolley","year":"1990","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.schres.2013.08.001_bb0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archpsyc.1982.04290010048009","article-title":"Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia","volume":"39","author":"Kane","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2013.08.001_bb0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2013.08.001_bb0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-0447.2008.01213.x","article-title":"Rates and predictors of remission and recovery during 3years in 392 never-treated patients with schizophrenia","volume":"118","author":"Lambert","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.schres.2013.08.001_bb0160","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"9831","key":"10.1016\/j.schres.2013.08.001_bb0165","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2013.08.001_bb0175","first-page":"13","article-title":"Prediction of outcome in first-episode schizophrenia","volume":"54","author":"Lieberman","year":"1993","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2013.08.001_bb0170","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.1993.01820170047006","article-title":"Time course and biologic correlates of treatment response in first-episode schizophrenia","volume":"50","author":"Lieberman","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2013.08.001_bb0180","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.psychres.2007.07.012","article-title":"Partial compliance in schizophrenia and the impact on patient outcomes","volume":"161","author":"Llorca","year":"2008","journal-title":"Psychiatry Res."},{"issue":"11","key":"10.1016\/j.schres.2013.08.001_bb0185","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1017\/S0033291707002656","article-title":"Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service","volume":"38","author":"Malla","year":"2008","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.schres.2013.08.001_bb0190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4088\/PCC.08r00612","article-title":"Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review","volume":"11","author":"Masand","year":"2009","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2013.08.001_bb0195","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1600-0447.1989.tb03032.x","article-title":"The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group","volume":"80","author":"McCreadie","year":"1989","journal-title":"Acta Psychiatr. Scand."},{"issue":"10","key":"10.1016\/j.schres.2013.08.001_bb0200","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1017\/S0033291706007951","article-title":"A systematic review of longitudinal outcome studies of first-episode psychosis","volume":"36","author":"Menezes","year":"2006","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.schres.2013.08.001_bb0205","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"9","key":"10.1016\/j.schres.2013.08.001_bb0210","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1176\/ajp.143.9.1155","article-title":"Outcome study of first-episode psychosis. I: Relapse rates after 1year","volume":"143","author":"Rabiner","year":"1986","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2013.08.001_bb0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/schbul\/18.2.185","article-title":"The natural course of schizophrenia: a review of first-admission studies","volume":"18","author":"Ram","year":"1992","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.schres.2013.08.001_bb0220","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archpsyc.1977.01770220097011","article-title":"Fluphenazine decanoate, oral fluphenazine, and placebo in treatment of remitted schizophrenics. II. Rating scale data","volume":"34","author":"Rifkin","year":"1977","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2013.08.001_bb0225","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","article-title":"Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder","volume":"56","author":"Robinson","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2013.08.001_bb0230","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archpsyc.1978.01770300115013","article-title":"Research diagnostic criteria: rationale and reliability","volume":"35","author":"Spitzer","year":"1978","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2013.08.001_bb0235","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.schres.2011.11.021","article-title":"Antipsychotic treatment for schizophrenia in the maintenance phase: a systematic review of the guidelines and algorithms","volume":"134","author":"Takeuchi","year":"2012","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2013.08.001_bb0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archpsyc.1997.01830130055011","article-title":"Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment","volume":"54","author":"Viguera","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2013.08.001_bb0245","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/oxfordjournals.schbul.a033315","article-title":"Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort","volume":"24","author":"Wiersma","year":"1998","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2013.08.001_bb0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00433729","article-title":"A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency","volume":"78","author":"Wistedt","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.schres.2013.08.001_bb0255","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4088\/JCP.v68n0502","article-title":"Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome","volume":"68","author":"Wunderink","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2013.08.001_bb0265","series-title":"The Early Stages of Schizophrenia","author":"Zipursky","year":"2001"},{"key":"10.1016\/j.schres.2013.08.001_bb0260","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbs135","article-title":"The myth of schizophrenia as a progressive brain disease","author":"Zipursky","year":"2013","journal-title":"Schizophr. Bull."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996413004362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996413004362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T16:29:44Z","timestamp":1539448184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996413004362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":53,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0920996413004362"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2013.08.001","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of symptom recurrence with medication discontinuation in first-episode psychosis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2013.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}